VCYT

$0.00

(

0.00%

)
Quote details

stock

Veracyte Inc

NASDAQ | VCYT

47.07

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

$3.77B

Market Cap

125.55

P/E Ratio

0.38

EPS

$50.71

52 Week High

$22.61

52 Week Low

HEALTHCARE

Sector

VCYT Chart

Recent Chart
Price Action

VCYT Technicals

Tags:

VCYT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $298M
Total Revenue $446M
Cost Of Revenue $148M
Costof Goods And Services Sold $148M
Operating Income $16M
Selling General And Administrative $178M
Research And Development $69M
Operating Expenses $282M
Investment Income Net -
Net Interest Income $11M
Interest Income $11M
Interest Expense $2K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $23M
Income Before Tax $26M
Income Tax Expense $1.6M
Interest And Debt Expense -
Net Income From Continuing Operations $24M
Comprehensive Income Net Of Tax -
Ebit $26M
Ebitda $49M
Net Income $24M

Revenue & Profitability

VCYT Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $298M
Total Revenue $446M
Cost Of Revenue $148M
Costof Goods And Services Sold $148M
Operating Income $16M
Selling General And Administrative $178M
Research And Development $69M
Operating Expenses $282M
Investment Income Net -
Net Interest Income $11M
Interest Income $11M
Interest Expense $2K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $23M
Income Before Tax $26M
Income Tax Expense $1.6M
Interest And Debt Expense -
Net Income From Continuing Operations $24M
Comprehensive Income Net Of Tax -
Ebit $26M
Ebitda $49M
Net Income $24M

VCYT News

VCYT Profile

Veracyte Inc Profile

Sector: HEALTHCARE

Industry: DIAGNOSTICS & RESEARCH

Veracyte, Inc. is a leading genomic diagnostics company headquartered in South San Francisco, California, specializing in innovative tests to improve patient care and diagnostic accuracy. With a focus on transforming the diagnosis of cancer and other diseases, Veracyte leverages its unique genomic technologies to provide actionable insights for clinicians and patients globally. The company is committed to expanding its comprehensive portfolio of diagnostic solutions, driving advancements in precision medicine, and enhancing patient outcomes through robust genomic testing.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
INHD
-1.55%
$0.22
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
SNAP
+0.14%
$7.62
ONMD
+45.07%
$2.06
ASST
+0.88%
$1.14
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
CIFR
+10.05%
$21.07
PLUG
+2.09%
$2.02
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
DEFT
+11.51%
$1.55
NIO
+0.36%
$5.48
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
F
+0.68%
$13.28
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
GOOGL
-0.60%
$318.02
SOFI
+3.18%
$29.39
BTG
+3.37%
$4.62
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
IBRX
+11.50%
$2.37
CAN
+12.59%
$1.03
WULF
+5.18%
$15.61
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
DVLT
-3.75%
$2.05
NGD
+5.86%
$8.30
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
APLD
+7.21%
$26.74
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
AMD
+0.97%
$216.32
CRCG
+21.27%
$2.85
KO
+0.37%
$72.88
VALE
+0.63%
$12.59
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
ZIM
+0.97%
$19.70
ORCL
-1.88%
$201.09
AMC
+6.95%
$2.46
HL
+4.61%
$16.70
PLTR
+0.77%
$167.05
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
INHD
-1.55%
$0.22
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
SNAP
+0.14%
$7.62
ONMD
+45.07%
$2.06
ASST
+0.88%
$1.14
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
CIFR
+10.05%
$21.07
PLUG
+2.09%
$2.02
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
DEFT
+11.51%
$1.55
NIO
+0.36%
$5.48
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
F
+0.68%
$13.28
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
GOOGL
-0.60%
$318.02
SOFI
+3.18%
$29.39
BTG
+3.37%
$4.62
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
IBRX
+11.50%
$2.37
CAN
+12.59%
$1.03
WULF
+5.18%
$15.61
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
DVLT
-3.75%
$2.05
NGD
+5.86%
$8.30
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
APLD
+7.21%
$26.74
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
AMD
+0.97%
$216.32
CRCG
+21.27%
$2.85
KO
+0.37%
$72.88
VALE
+0.63%
$12.59
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
ZIM
+0.97%
$19.70
ORCL
-1.88%
$201.09
AMC
+6.95%
$2.46
HL
+4.61%
$16.70
PLTR
+0.77%
$167.05
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.